Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Mediclinic upbeat about Middle East turnaround

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Global private hospital group Mediclinic (MDC) is more optimistic about its struggling Middle East division. The firm has also dodged a proposed tax levy in Switzerland.
On 10 April the canton of Zurich, a federal state of Switzerland, rejected a proposed levy on the proportion of privately insured patients treated in listed hospitals, which included Mediclinic’s Klinik Hirslanden.
The Switzerland division represents approximately 50% of earnings and the annual CHF34m levy would have hit 2017 earnings by 10% according to analysts.
It’s welcome news for Mediclinic after its Middle East division suffered in 2016 thanks to regulatory changes. From 1 July 2016, United Arab Emirates citizens lost access to free healthcare in Abu Dhabi and had to make a 20% co-payment if they visited a private hospital. This saw full year March 2017 revenue from this part of the business fall by 8% year-on-year.
Investec analyst Cora McCallum also says a slower than expected ramp up in patients is taking its toll as new doctors are taking time to establish their reputation and build a practice.
Despite the challenging environment, management is upbeat about the division’s fortunes improving throughout its 2018 financial year. Margins are also anticipated to be ahead of previous guidance at up to 11.5%. (LMJ)
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.